Clinical trials in large scale to Stockholm

Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per study, so that companies do not have to go abroad for clinical trials.

Hur stoppa vaccinskräcken?

Chatt inspirerade till bättre molnberäkningar

En grupp forskare har byggt en ny teknik för molnberäkningar. Istället för fråga-svar principen bygger programmet på omvänd kommunikation mellan server och dator. - Webbtjänster används mycket i biovetenskaper, säger en av forskarna, Ola Spjuth.

Utmärkelse till KIs rektor

"För sin enastående inverkan på vetenskapen och förmåga att inspirera andra" uppmärksammas Karolinska Institutets rektor Harriet Wallberg-Henriksson vid en ceremoni i San Francisco idag.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

View pathology images in your iPhone

The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.

Danish discovery could help cardiac patients

The Danish researchers have developed a component that could make live easier forpatients with heart failure.

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

Sales Representative, Applied Biosystems

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.